Author: Not Specified
Source: PR Newswire
Interest: Amplimmune, Inc. announced that it has entered into a broad strategic alliance with GlaxoSmithKline (GSK) to further develop PD-1 targeting therapies that may be effective in the treatment of cancer and other diseases.
GlaxoSmithKline and Amplimmune Form Global Strategic Collaboration






Loading...